Antiphospholipid and antisynthetase syndrome in a patient with polymyositis-rheumatoid arthritis overlap

dc.contributor.author	Ponyi, Andrea
dc.contributor.author	Constantin, Tamás
dc.contributor.author	Dankó, Katalin
dc.date.accessioned	2017-06-21T12:19:07Z
dc.date.available	2017-06-21T12:19:07Z
dc.date.issued	2004
dc.identifier	4444289753
dc.identifier.citation	pagination=371-372; journalVolume=23; journalIssueNumber=4; journalTitle=CLINICAL RHEUMATOLOGY;
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/4257
dc.identifier.uri	doi:10.1007/s10067-004-0903-x
dc.description.abstract	Idiopathic inflammatory myopathies, mainly polymyositis (PM) may occur in the course of several autoimmune diseases. The overlapping forms of myositis, when the patient also meets the criteria for rheumatoid arthritis (RA), affect 3%-5% of myositis patients [1]. To the best of our knowledge this is the first report on the overlapping form of RA, antiphospholipid syndrome (APS) and the serological subgroup of PM, the antisynthetase syndrome (ASS).
dc.relation.ispartof	urn:issn:0770-3198
dc.title	Antiphospholipid and antisynthetase syndrome in a patient with polymyositis-rheumatoid arthritis overlap
dc.type	Journal Article
dc.date.updated	2017-04-05T07:41:04Z
dc.language.rfc3066	en
dc.identifier.mtmt	1633280
dc.identifier.wos	000223023900019
dc.identifier.pubmed	15293105
dc.contributor.department	SE/AOK/K/II. Sz. Gyermekgyógyászati Klinika
dc.contributor.institution	Semmelweis Egyetem